ranolazine 500 mg
1 INDICATIONS AND USAGE Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. ( 1 )
actavis pharma, inc.
OVAL WHITE logo 418
logo 418 OVAL WHITE
Related Pills
12 HR ranolazine 500 MG Extended Release Oral Tablet
actavis pharma, inc.
ranolazine tablet film coated extended release
actavis pharma, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RANOLAZINE extended-release tablets are supplied as follows: 500 mg - Each gray, oval shaped, film-coated tablet debossed with and 418 on one side and plain on the other side contains 500 mg of
RANOLAZINE. Tablets are supplied in bottles of 60 tablets (NDC 45963-418-06). 1,000 mg - Each pink, oval shaped, film-coated tablet debossed with and 419 on one side and plain on the other side contains 1,000 mg of
RANOLAZINE. Tablets are supplied in bottles of 60 tablets (NDC 45963-419-06). Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP. 1 1
More pills like OVAL logo 418